Epigenetics in neonatal necrotizing enterocolitis: current understanding and the potential involvement of m6A modification

新生儿坏死性小肠结肠炎的表观遗传学:目前的认识以及m6A修饰的潜在作用

阅读:1

Abstract

Necrotizing enterocolitis (NEC) exhibits high incidence, surgical intervention rates, and mortality among preterm infants, profoundly impacting survivor's long-term quality of life. Consequently, the etiology and pathogenesis of this disease remain incompletely elucidated. Emerging evidence underscores the intricate connection between epigenetics and NEC. DNA methylation, histone modifications, and non-coding RNAs regulate disease development through targeted modification of transcriptional regulation and translational control in NEC-associated genes, thereby driving pathological progression. Notably, N6-methyladenosine (m6A) modification, the most prevalent form of RNA epigenetic regulation, exerts critical functions in intestinal inflammation, microbial homeostasis, and injury repair, suggesting its potential involvement in NEC development. In this review, we will summarize the current mechanistic understanding of NEC, emphasizing its interplay with epigenetics (DNA methylation, histone modifications, and non-coding RNAs). we also explore the emerging role of m6A RNA modification in gut pathophysiology, proposing its potential role in NEC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。